LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market Size, 2028

LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Industry Trends Analysis Report By Modality (Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging), By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 71 | Format: PDF | Report ID: KBV-18088

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market

Market Report Description

The Latin America, Middle East and Africa Coronary Heart Disease Diagnostic Imaging Devices Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028).

IVUS has evolved into a valuable technique for assessing and characterizing coronary arteries and atherosclerotic plaques. IVUS is an invasive method that employs a tiny ultrasound transducer attached to a catheter similar to those used in coronary angioplasty to produce images. The catheter is pushed through the coronary artery on a wire until it reaches a point distal to the segment to be investigated. As the catheter is gently brought out, a series of tomographic pictures of the coronary artery are taken. As the catheter is gently brought out, a series of tomographic pictures of the coronary artery are taken. Each IVUS image shows the sections of the coronary artery (intima, medium, and adventitia) as well as the lumen in a 360° cross-section. Online 3-dimensional reconstructions of a plaque's length, volume, and reference landmarks are now possible with modern technologies. Therefore, with the rapidly going technological advancements all over the world, the demand for coronary heart imaging diagnostic imaging solutions is increasing. This factor is estimated to propel the growth of the market in the coming years.

Smoking, hypertension, hyperlipidemia, diabetes, obesity, hyperlipidemia, physical inactivity, and poor dietary habits, all of which are modifiable atherothrombotic CVD risk factors in HIC populations, are now palpably emerging in SSA. However, the full cost of these risk factors and their consequences in SSA is unknown since most countries lack data or have insufficient data collection methods that are not reliable enough to allow for a proportionate health-system response.

Smoking rates are 10% in Sub-Saharan Africa versus 30% in High-Income Countries. Hypertension prevalence is 30% in Sub-Saharan Africa (40% in urban and 20% in rural populations) versus 20% in Higher Income Countries. Diabetes prevalence is 7.1% in men and women in SSA versus 6–8% in men as well as 3–6% in women in High-Income Countries. Dyslipidemia prevalence in adults is 25% in SSA versus 40–60 % in HIC. In the account of these numbers, the region is estimated to witness a very high prevalence of cardiovascular disorders in the coming years. This factor would increase the demand for effective imaging devices across the region. Therefore, the regional market is anticipated to flourish owing to these reasons.

The Brazil market dominated the LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $35.3 Million by 2028. The Argentina market is experiencing a CAGR of 10.5% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 9.7% during (2022 - 2028).

Based on Modality, the market is segmented into Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Coronary Heart Disease Diagnostic Imaging Devices Market is Predict to reach $2.1 Billion by 2028, at a CAGR of 6.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).

Scope of the Study

Market Segments Covered in the Report:

  • Nuclear Medicine
  • Computed Tomography
  • Ultrasound
  • X rays
  • Magnetic Resonance Imaging

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Mindray Medical International Limited
  • Chison Medical Technologies Co., Ltd.
  • Analogic Corporation (Altaris Capital Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Coronary Heart Disease Diagnostic Imaging Devices Market Report 2022-2028

North America Coronary Heart Disease Diagnostic Imaging Devices Market Report 2022-2028

Europe Coronary Heart Disease Diagnostic Imaging Devices Market Report 2022-2028

Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities